21.04.2015 23:59:00
|
Horizon Pharma, Inc. -- Moody's Publishes Covenant Quality Assessment for Horizon Pharma Financing Inc. (to be merged with and into Horizon Pharma, Inc.) Bond Offering
New York, April 21, 2015 -- Moody's Investors Service has assigned an overall covenant quality score of 3.53 to Horizon Pharma Financing Inc.'s$300m _% Senior Notes due 2023. Subscribers can read the full report at: